Sumitomo Pharma Co.,Ltd. FY2027 Q1 Earnings Report

Quick View

Executive Summary

In Q1 (IFRS), the Company posted a mixed set of results, with revenue growth and a decline in operating income, alongside revenue growth and an increase in net income. Profitability at the operating level deteriorated due to a higher cost ratio, while bottom-line profit increased substantially as a result of improved non-operating income and expenses. Revenue was ¥129.495B (+19.9% year on year), operating income was ¥18.188B (-10.8%), profit before tax was ¥18.295B (+53.3%), and net income attributable to owners of the parent (hereinafter, “net income”) was ¥16.997B (+51.7%). The increase in revenue was driven by the consolidation of the operating structure for the Company’s core U.S. products. The transition to a single business segment was also implemented from the current period. The decline in operating income was primarily attributable to a lower gross margin resulting from the increase in the cost ratio, while the increase in net income resulted from a substantial reduction in finance costs and the conversion of equity-method investment losses into profits. The differing directions of operating income and net income were the defining characteristics of these results.

Factors Affecting Performance

【Revenue】Revenue was ¥129.495B, representing a year-on-year increase of +19.9%. From Q1, the assets, including patent rights, related to the three core U.S. products were transferred from a wholly owned subsidiary to the Company itself. The Company consequently changed to an operating structure under which the allocation of management resources and performance evaluation are conducted on an integrated basis within a single Pharmaceutical Business segment. Accordingly, disclosure of the breakdown by segment has been omitted.

【Profit and Loss】Cost of sales increased by +39.3% year on year to ¥61.41B, while the gross margin declined to 52.6% from 59.2%, a decrease of -6.6pt. Selling, general and administrative expenses were ¥39.24B (+10.1%), and research and development expenses were ¥11.43B (8.8% of revenue). Although both grew more slowly than revenue (+19.9%), they were insufficient to absorb the decline in gross margin, resulting in a 10.8% year-on-year decrease in operating income to ¥18.19B. Meanwhile, finance costs fell sharply from ¥9.05B in the previous year to ¥2.09B, and equity-method investment gains and losses turned from a loss of -¥0.64B in the previous year to a gain of +¥0.44B. Consequently, profit before tax increased by +53.3% to ¥18.29B. The effective tax rate remained low at 7.1% compared with 6.1% in the previous year, and net income increased substantially by +51.7% to ¥16.997B. In conclusion, the results represent a coexistence of revenue growth with lower profit on an operating-income basis and revenue growth with higher profit on a net-income basis, with the latter driven by non-operating factors.

Key Financial Indicators

【Profitability】The operating margin declined to 14.0% from 18.9%, a decrease of -4.8pt, while the gross margin declined to 52.6% from 59.2%, a decrease of -6.6pt. In contrast, the net profit margin improved to 13.1% from 10.4%, an increase of +2.8pt, indicating divergent profitability trends at the operating and bottom-line levels.【Cash Flow Quality】Operating cash flow (OCF) was -¥7.44B, substantially below net income of ¥16.997B, indicating that cash-generation capacity was not commensurate with the reported profit level.【Investment Efficiency】ROE was 4.2%, based on a DuPont decomposition comprising a net profit margin of 13.1%, total asset turnover of 0.153x (quarterly basis), and financial leverage of 2.07x. The low total asset turnover constrained ROE.【Financial Soundness】The equity ratio improved to 48.4% from 36.4%, an increase of +12.0pt, while long-term borrowings were reduced by -33.2% year on year to ¥119.66B. Goodwill was ¥214.39B, equivalent to 52.5% of equity attributable to owners of the parent of ¥40.86B, indicating a high degree of reliance on goodwill in the asset structure.

Cash Flow Analysis

Operating cash flow was -¥7.44B, compared with -¥0.19B in the previous year, representing a substantial divergence from net income of ¥16.997B. The primary factor was a deterioration in working capital: trade receivables increased by ¥7.28B, trade payables decreased by ¥8.73B, and other working capital items made a negative contribution of -¥28.86B, while inventories decreased by ¥5.88B and contributed positively to cash flow. Investing cash flow was +¥0.05B, approximately balanced, with capital expenditures of ¥0.66B remaining below depreciation and amortization expense of ¥4.899B. As a result, free cash flow was -¥7.39B. Financing cash flow was strongly positive at +¥39.15B, primarily comprising ¥96.88B of funding raised through the issuance of new shares and repayment of ¥60B in long-term borrowings. Cash and cash equivalents increased by +¥32.33B from ¥44.31B at the beginning of the period to ¥76.64B at period-end; however, this increase resulted from capital financing rather than operating activities.

Earnings Quality

The increase in net income was achieved through an improvement in non-operating income and expenses despite a decline in the operating margin (-4.8pt), and this distinction is important when assessing earnings quality. The substantial decrease in finance costs from ¥9.05B in the previous year to ¥2.09B, together with the conversion of equity-method investment losses from -¥0.64B in the previous year into gains of +¥0.44B, was the primary driver of the +53.3% increase in profit before tax. These factors include recurring but temporary improvement drivers separate from the profitability of the core business. In addition, OCF of -¥7.44B was substantially below net income of ¥16.997B, indicating a significant divergence between accrual-based earnings and cash flows, which warrants attention from an earnings-quality perspective. Comprehensive income was ¥18.91B, exceeding net income by ¥1.91B. This difference was primarily attributable to foreign currency translation adjustments for foreign operations of +¥1.80B, representing a foreign-exchange factor distinct from business operating performance.

Earnings Forecast and Guidance

Progress against the full-year earnings forecast was 24.0% for revenue (¥129.495B/¥540B), 20.2% for operating income (¥18.188B/¥90B), and 22.1% for net income (¥16.997B/¥77B), all below the 25% benchmark for even quarterly progress. Operating income had the lowest progress rate, at 20.2%, while the full-year plan itself anticipates a year-on-year decline of -16.2%. Although the earnings forecast was revised during the current quarter, there was no revision to the dividend forecast. The progress rates suggest a plan weighted toward the second half of the fiscal year, with the extent of gross-margin recovery and expense trends expected to determine future progress.

Shareholder Returns

The dividend forecast for the fiscal year ending March 2027 is currently undetermined. Dividend payments during the current quarter were ¥0.001B, remaining at the same negligible level as in the same period of the previous year, while share repurchases were also limited to less than ¥0.001B. During the current period, the Company raised ¥96.88B through the issuance of new shares, suggesting that strengthening the financial foundation is being prioritized over shareholder returns.

Risk Factors

1. Goodwill impairment risk: Goodwill was ¥214.39B, reaching 52.5% of equity attributable to owners of the parent of ¥40.86B. Depending on future profitability trends, impairment recognition could affect net assets, making this an item requiring monitoring.

2. Quality of operating cash flow: OCF was -¥7.44B, representing a substantial divergence from net income of ¥16.997B. The primary factors were deterioration in working capital, including an increase of +¥7.28B in trade receivables and a decrease of -¥8.73B in trade payables. Ongoing monitoring of the relationship between earnings and cash generation is required.

3. Progress toward achieving the full-year plan: The full-year progress rate for operating income was 20.2%, below the standard quarterly progress benchmark of 25%. The gross margin declined by -6.6pt from the previous year, and achieving the full-year plan, which anticipates a year-on-year decline of -16.2%, will require profitability to improve from the second half onward.

Industry Benchmarks (For Reference; Compiled by the Company)

Profitability and Returns

The operating margin was below the industry median, while the net profit margin was substantially above the median, indicating that the Company’s positioning within the industry differs depending on the stage of the income statement.

Growth and Capital Efficiency

The revenue growth rate was substantially above the industry median, demonstrating a high rate of revenue growth within the industry.

Source: Compiled by the Company

Key Takeaways from the Financial Results

1. Although the decline in gross margin (-6.6pt) resulted in a -10.8% decrease in operating income, net income increased by +51.7% due to lower finance costs and improved equity-method investment gains and losses. The differing trends on an operating-income basis and a net-income basis demonstrate the need to distinguish between the profitability of the core business and non-operating factors.

2. The equity ratio improved to 48.4% from 36.4% in the previous year as a result of the issuance of new shares (¥96.88B) and repayment of ¥60B in long-term borrowings. Although financial soundness improved, the fact that goodwill accounted for 52.5% of equity attributable to owners of the parent remains an observation point when assessing B/S quality.

3. OCF was -¥7.44B, below net income, while progress against the full-year plan was also below the standard quarterly benchmark, at 24.0% for revenue, 20.2% for operating income, and 22.1% for net income. Normalization of working capital and recovery in profitability during the second half are key points to watch in assessing achievement of the full-year plan.

Theoretical Share Price (Reference Value)

This is a reference range mechanically calculated solely from publicly available data using a residual income model (Ohlson-type, with an explicit five-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥1,204–¥1,277 at ±1% for the cost of equity, and ¥1,231–¥1,253 at ±0.1 for ω.

Notes:

• Goodwill represents a high proportion of net assets, and the assumptions would change substantially if impairment were recognized.
• Net assets as of the end of the quarter are used; there is a timing difference between these figures and the full-year forecast.

(Calculation model: Residual income model / Interest rate reference month: 2026-06 / This figure does not predict or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional adviser as necessary.

---End of Report---